Innovation
2 patent families — focus: Human necessities; filing pace active. Cited 36 times.
| Year | Filings |
|---|---|
| 2025 | 1 |
| 2026 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developer of therapeutics to treat neuroinflammation
2 patent families — focus: Human necessities; filing pace active. Cited 36 times.
| Year | Filings |
|---|---|
| 2025 | 1 |
| 2026 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |